Approach to Chelating Radioactivity using Carbon Dots for Positron Emission Tomography Imaging
Source abstract
Abstract
With the rapid development of the radiotheranostic field, developing new methods to produce radiolabeled agents has become a critical area of exploration. We hypothesized that the inert carbon shell of carbon dots (CDs) could serve as a robust chelation strategy to overcome the stability issue of radiometal complexes, including the recoil energy issue of alpha (α)-emitting radioisotopes. To investigate this, we utilized radioactive copper-64 ( 64 Cu) as a surrogate for therapeutic isotopes and optimized a synthetic route for encapsulating 64 Cu within CDs ( 64 Cu@C). Our findings confirmed that CDs effectively encapsulated 64 Cu with minimal leakage. Positron emission tomography (PET) imaging of 64 Cu@C in tumor-bearing rodent models showed a predominant uptake in the liver. To improve tumor targeting, we implemented two strategies: (1) encapsulating 64 Cu@C within PEGylated liposomes ( 64 Cu@C-PEGLipo) as nanocarriers, and (2) preinjecting positively charged liposomes (DOTAPLipo) to block the reticuloendothelial system prior to administering 64 Cu@C (DOTAPLipo-preinjected- 64 Cu@C). These approaches resulted in 1.7-fold and 2.5-fold increases in tumor uptake, respectively, at 1 h postinjection. In conclusion, these findings highlight the potential of CDs as a stable platform for radiometal encapsulation and demonstrate effective strategies for enhancing tumor-specific delivery in radiotheranostic applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Carbon and Quantum Dots Applications · Opportunistic and Delay-Tolerant Networks · Age of Information Optimization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Center for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy
University of North Carolina at Chapel Hill
Department of Radiology, Biomedical Research Imaging Center, Lineberger Comprehensive Cancer Center
Joint Department of Biomedical Engineering
Department of Nuclear Medicine
Zhujiang Hospital of Southern Medical University
Department of Chemistry, University of Georgia, 302 East Campus Road, Athens, Georgia 30602, United States
References (64)
Show source-provided references
1. 10.1038/s41573-020-0073-910.1038/s41573-020-0073-9 ↗
2. 10.1016/j.critrevonc.2018.01.00110.1016/j.critrevonc.2018.01.001 ↗
3. 10.1002/cmdc.20210013510.1002/cmdc.202100135 ↗
4. 10.2967/jnumed.116.18633810.2967/jnumed.116.186338 ↗
5. 10.1002/ird3.3010.1002/ird3.30 ↗
6. 10.1007/s11307-023-01857-y10.1007/s11307-023-01857-y ↗
7. 10.1007/s13277-011-0286-y10.1007/s13277-011-0286-y ↗
8. 10.1001/jamaoncol.2018.404410.1001/jamaoncol.2018.4044 ↗
9. 10.2967/jnumed.122.26535310.2967/jnumed.122.265353 ↗
10. 10.3389/fmed.2022.103431510.3389/fmed.2022.1034315 ↗
11. 10.1016/S1470-2045(23)00672-110.1016/S1470-2045(23)00672-1 ↗
12. 10.3389/fmed.2022.102018810.3389/fmed.2022.1020188 ↗
13. 10.3390/ph802032110.3390/ph8020321 ↗
14. 10.2967/jnumed.121.26268710.2967/jnumed.121.262687 ↗
15. 10.1021/acs.bioconjchem.2c0019010.1021/acs.bioconjchem.2c00190 ↗
16. 10.1007/s12274-020-2957-810.1007/s12274-020-2957-8 ↗
17. 10.3390/pharmaceutics1308112310.3390/pharmaceutics13081123 ↗
18. 10.1186/s12951-021-00963-910.1186/s12951-021-00963-9 ↗
19. 10.1021/acscentsci.0c0130610.1021/acscentsci.0c01306 ↗
20. 10.1016/j.mattod.2021.07.02810.1016/j.mattod.2021.07.028 ↗
21. 10.1016/j.cartre.2023.10027610.1016/j.cartre.2023.100276 ↗
22. 10.1002/bmm2.1204510.1002/bmm2.12045 ↗
23. 10.1039/D1RA08452F10.1039/D1RA08452F ↗
24. 10.1002/smsc.20220001210.1002/smsc.202200012 ↗
25. 10.1016/j.drudis.2018.01.00610.1016/j.drudis.2018.01.006 ↗
26. 10.1002/chem.20230398210.1002/chem.202303982 ↗
27. 10.3389/fchem.2023.122784310.3389/fchem.2023.1227843 ↗
28. 10.1039/D1NA00036E10.1039/D1NA00036E ↗
29. 10.1021/acsabm.1c0121510.1021/acsabm.1c01215 ↗
30. 10.1039/D0GC01014F10.1039/D0GC01014F ↗
31. 10.1002/advs.20220762110.1002/advs.202207621 ↗
32. 10.1039/C8CS00750K10.1039/C8CS00750K ↗
33. 10.1021/acsanm.1c0137210.1021/acsanm.1c01372 ↗
34. 10.1016/j.mtcomm.2021.10273210.1016/j.mtcomm.2021.102732 ↗
35. 10.1002/cey2.13410.1002/cey2.134 ↗
36. 10.1038/s41467-021-22902-w10.1038/s41467-021-22902-w ↗
37. 10.3390/nano1011231610.3390/nano10112316 ↗
38. 10.1039/D2RA07180K10.1039/D2RA07180K ↗
39. 10.1002/advs.20240547210.1002/advs.202405472 ↗
40. 10.1002/adma.20180274810.1002/adma.201802748 ↗
41. 10.1039/D0NR08166C10.1039/D0NR08166C ↗
42. 10.1021/acsanm.3c0358310.1021/acsanm.3c03583 ↗
43. 10.1039/C9NR05746C10.1039/C9NR05746C ↗
44. 10.1021/acsabm.0c0159710.1021/acsabm.0c01597 ↗
45. 10.1021/acsnano.2c0251810.1021/acsnano.2c02518 ↗
46. 10.1021/acs.inorgchem.9b0228310.1021/acs.inorgchem.9b02283 ↗
47. 10.23736/S1824-4785.20.03315-410.23736/S1824-4785.20.03315-4 ↗
48. 10.1186/s41181-024-00266-y10.1186/s41181-024-00266-y ↗
49. 10.1016/j.colsurfb.2018.11.04110.1016/j.colsurfb.2018.11.041 ↗
50. 10.1007/s00259-024-06754-210.1007/s00259-024-06754-2 ↗
51. 10.1039/C9TC01640F10.1039/C9TC01640F ↗
52. 10.1021/jp905912n10.1021/jp905912n ↗
53. 10.1002/anie.20130051910.1002/anie.201300519 ↗
54. 10.1021/acs.jpcc.6b1251910.1021/acs.jpcc.6b12519 ↗
55. 10.1038/s41377-022-00798-510.1038/s41377-022-00798-5 ↗
56. 10.1002/adfm.20130335210.1002/adfm.201303352 ↗
57. 10.1039/C8RA03180K10.1039/C8RA03180K ↗
58. 10.1039/C7NJ05000C10.1039/C7NJ05000C ↗
59. 10.3390/cancers1407174110.3390/cancers14071741 ↗
60. 10.3389/fmolb.2020.58701210.3389/fmolb.2020.587012 ↗
61. 10.1038/s41467-024-48838-510.1038/s41467-024-48838-5 ↗
62. 10.1126/science.683629410.1126/science.6836294 ↗
63. 10.7150/thno.1807810.7150/thno.18078 ↗
64. 10.1038/s41467-023-37150-310.1038/s41467-023-37150-3 ↗